<DOC>
	<DOCNO>NCT00129545</DOCNO>
	<brief_summary>This multi-center , prospective , randomize study , stratify center , compare WATCHMAN device long term warfarin therapy , demonstrate treatment arm non-inferior control arm . This study amend allow non-randomized arm increase enrollment .</brief_summary>
	<brief_title>WATCHMAN Left Atrial Appendage System Embolic PROTECTion Patients With Atrial Fibrillation</brief_title>
	<detailed_description>The WATCHMAN device design permanently implant distal ostium leave atrial appendage ( LAA ) trap potential embolus exit LAA .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Patient paroxysmal , persistent permanent nonvalvular atrial fibrillation ( AF ) Eligible long term warfarin CHADS score &gt; = 1 [ congestive heart failure ( CHF ) , history high blood pressure , 75 year age old , diabetes , prior stroke transient ischemic attack ( TIA ) ] Contraindicated warfarin Contraindicated aspirin clopidogrel ( Plavix ) Congestive heart failure ( CHF ) Class 4 Implanted mechanical valve Atrial septal Patent Foramen Ovale ( PFO ) device Platelets &lt; 100,000 hemoglobin &lt; 10 Left ventricular ejection fraction ( LVEF ) &lt; 30 %</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>AF</keyword>
	<keyword>A Fib</keyword>
	<keyword>Stroke</keyword>
	<keyword>Coumadin</keyword>
	<keyword>Warfarin</keyword>
	<keyword>Blood thin medication</keyword>
	<keyword>transient ischemic attack ( TIA )</keyword>
	<keyword>WATCHMAN</keyword>
	<keyword>Left atrial appendage</keyword>
	<keyword>LAA isolation</keyword>
	<keyword>LAA occlusion</keyword>
</DOC>